MDR
vs
S
S&P/ASX 300
MDR
Over the past 12 months, MDR has underperformed S&P/ASX 300, delivering a return of -76% compared to the S&P/ASX 300's +17% growth.
Stocks Performance
MDR vs S&P/ASX 300
Performance Gap
MDR vs S&P/ASX 300
Performance By Year
MDR vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Medadvisor Ltd
Glance View
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..
